Jones A G, Davison A, LaTegola M R, Brodack J W, Orvig C, Sohn M, Toothaker A K, Lock C J, Franklin K J, Costello C E, Carr S A, Biemann K, Kaplan M L
J Nucl Med. 1982 Sep;23(9):801-9.
Studies of the anionic coordination complex 99Tc-oxo[N,N'-ethylene-bis(2-mercaptoacetimido)]technetate(V) ([TcO(ema)]-) are described. Syntheses performed both at carrier levels (10(-5)M) and with no carrier added (less than 10(-8)M) indicate that the complex is formed virtually quantitatively from pertechnetate ion over this range. Tissue distributions in normal rats are similar at both concentrations up to one hour after administration. It has been shown--using a combination of high-pressure liquid chromatography and field-desorption mass spectrometry--that the anion is excreted unchanged into both urine and bile. The effectiveness of this N2S2 donor set in sequestering Tc-99m, and the in vivo stability of the resulting complex, suggest that modified chelates of this structural class could provide a series of useful diagnostic agents.
本文描述了阴离子配位络合物99锝-氧代[N,N'-亚乙基-双(2-巯基乙酰亚胺)]锝(V)([TcO(ema)]-)的研究。在载体浓度(10^(-5)M)和无载体添加(小于10^(-8)M)条件下进行的合成表明,在此范围内,该络合物几乎定量地由高锝酸根离子形成。给药后一小时内,两种浓度下正常大鼠的组织分布相似。已通过高压液相色谱和场解吸质谱联用表明,该阴离子以不变的形式排泄到尿液和胆汁中。这种N2S2供体组在螯合99m锝方面的有效性以及所得络合物的体内稳定性表明,这种结构类型的修饰螯合物可以提供一系列有用的诊断剂。